Coverage note
Microbiome testing company Tiny Health clinches $33M to scale research, enterprise partnerships
Read the original at Fierce Healthcare
Read “Microbiome testing company Tiny Health clinches $33M to scale research, enterprise partnerships” at Fierce Healthcare →Machine-written summary. The paragraph and the list below were written by a language model reading Fierce Healthcare's article, not by The 5:45's editors, and they describe that article rather than add to it. (model: @cf/ibm-granite/granite-4.0-h-micro) The original, linked above, is the actual reporting.
Tiny Health, a microbiome testing company, has secured $33 million in a series B funding round led by Capital B, signaling strong investor confidence in the company's potential to advance research and expand its enterprise partnerships. The funding will be used to enhance research efforts, improve provider education, scale the B2B platform, and grow the patient-facing AI agent. Tiny Health's innovative approach to gut microbiome testing and its commitment to precision medicine make it a significant player in the healthcare industry.
What Fierce Healthcare reported
- Tiny Health raised $33 million in a series B funding round led by Capital B, bringing the company's total raised capital to $46 million.
- The company now has over 6,000 practitioners on its platform and 47 enterprise partners, with its B2B platform growing fourfold last year.
- Tiny Health has launched a $5 million Microbiome Research Program to support researchers, clinicians, and scientific partners in investigating microbiome health intervention strategies